Shobita and Jack talk about how patents might shape access to a COVID-19 vaccine. And, in light of a recent report by the US and UK national scientific academies, we talk about heritable human genome editing (using CRISPR-Cas9) and the role that the world's citizens might play in deciding whether and how it might proceed, with Ben Hurlbut, Associate Professor in the School of Life Sciences at Arizona State University.